GLP1R and Parkinson disease: Notably, the treatment of EcN showed slight or no impact on the expression of those proteins, indicating that GLP‐1 and its analog were taking a leading position in regulating the expression of critical proteins induced by MPTP in PD mice (Figure 4a).